Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 5
2007 3
2008 3
2010 4
2011 2
2012 5
2013 2
2014 2
2015 8
2016 9
2017 9
2018 10
2019 9
2020 23
2021 10
2022 11
2023 11
2024 10
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Advancing drug development in myelodysplastic syndromes.
Mina A, McGraw KL, Cunningham L, Kim N, Jen EY, Calvo KR, Ehrlich LA, Aplan PD, Garcia-Manero G, Foran JM, Garcia JS, Zeidan AM, DeZern AE, Komrokji R, Sekeres MA, Scott B, Buckstein R, Tinsley-Vance S, Verma A, Wroblewski T, Pavletic S, Norsworthy K. Mina A, et al. Among authors: scott b. Blood Adv. 2025 Mar 11;9(5):1095-1104. doi: 10.1182/bloodadvances.2024014865. Blood Adv. 2025. PMID: 39786387 Free PMC article. Review.
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.
Luque Paz D, Gagelmann N, Benajiba L, Riou J, Salit R, Orvain C, Schroeder T, Bories C, Gurnari C, Badbaran A, Boyer F, Pagliuca S, Rautenberg C, Tavitian S, Pangiota V, Ianotto JC, Thol F, Cayssials E, Heuser M, Rubio MT, Cassinat B, Daltro de Oliveira R, Sauter C, Maciejewski JP, Reinhardt HC, Scott BL, Ugo V, Kröger N, Kiladjian JJ, Robin M. Luque Paz D, et al. Among authors: scott bl. Blood Adv. 2025 Feb 25;9(4):797-807. doi: 10.1182/bloodadvances.2024014368. Blood Adv. 2025. PMID: 39561372 Free PMC article.
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib.
Gagelmann N, Bose P, Gupta V, McLornan DP, Vachhani P, Al-Ali HK, Ali H, Treskes P, Buckley S, Roman-Torres K, Scott B. Gagelmann N, et al. Among authors: scott b. Clin Lymphoma Myeloma Leuk. 2024 Nov;24(11):796-803. doi: 10.1016/j.clml.2024.06.012. Epub 2024 Jul 2. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39034203 Free article. Clinical Trial.
PATIENTS AND METHODS: In order to assess the impact of baseline blood counts on pacritinib efficacy, an analysis of efficacy outcomes by baseline platelet and hemoglobin levels was performed using data pooled from 2 Phase 3 studies of pacritinib in patients with MF (PERSIS …
PATIENTS AND METHODS: In order to assess the impact of baseline blood counts on pacritinib efficacy, an analysis of efficacy outcomes …
Pediatric Hematology and Oncology Patients on Extracorporeal Membrane Oxygenation: Outcomes in a Multicenter, Retrospective Cohort, 2009-2021.
Mowrer MC, Lima L, Nair R, Li X, Sandhu H, Bridges B, Barbaro RP, Bhar S, Nkwantabisa R, Ghafoor S, Reschke A, Olson T, Malone MP, Shah N, Zinter MS, Gehlbach J, Hollinger L, Scott BL, Lerner RK, Brogan TV, Raman L, Potera RM. Mowrer MC, et al. Among authors: scott bl. Pediatr Crit Care Med. 2024 Nov 1;25(11):1026-1034. doi: 10.1097/PCC.0000000000003584. Epub 2024 Jul 19. Pediatr Crit Care Med. 2024. PMID: 39028213
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.
Jain T, Estrada-Merly N, Salas MQ, Kim S, DeVos J, Chen M, Fang X, Kumar R, Andrade-Campos M, Elmariah H, Agrawal V, Aljurf M, Bacher U, Badar T, Badawy SM, Ballen K, Beitinjaneh A, Bhatt VR, Bredeson C, DeFilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi AP, Ganguly S, Gergis U, Grunwald MR, Hamad N, Hamilton BK, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-Dabaja MA, Krem MM, Lad DP, Liesveld J, Al Malki MM, Malone AK, Murthy HS, Ortí G, Patel SS, Pawarode A, Perales MA, van der Poel M, Ringden O, Rizzieri DA, Rovó A, Savani BN, Savoie ML, Seo S, Solh M, Ustun C, Verdonck LF, Wingard JR, Wirk B, Bejanyan N, Jones RJ, Nishihori T, Oran B, Nakamura R, Scott B, Saber W, Gupta V. Jain T, et al. Among authors: scott b. Blood Adv. 2024 Aug 27;8(16):4281-4293. doi: 10.1182/bloodadvances.2024013451. Blood Adv. 2024. PMID: 38916866 Free PMC article.
We evaluate the impact of donor types on outcomes of hematopoietic cell transplantation (HCT) in myelofibrosis, using the Center for International Blood and Marrow Transplant Research registry data for HCTs done between 2013 and 2019. ...In study-eligible 1032 patients who …
We evaluate the impact of donor types on outcomes of hematopoietic cell transplantation (HCT) in myelofibrosis, using the Center for Interna …
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation.
Rathje K, Gagelmann N, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol F, Robin M, Oechsler S, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N. Rathje K, et al. Among authors: scott bl. Bone Marrow Transplant. 2024 Aug;59(8):1154-1160. doi: 10.1038/s41409-024-02291-6. Epub 2024 May 21. Bone Marrow Transplant. 2024. PMID: 38773281 Free PMC article.
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Kopmar NE, Othus M, Quach K, Rasmussen A, Schonhoff K, Becker PS, Walter RB, Halpern AB, Salit R, Cassaday RD, Shustov A, Stewart FM, Oehler VG, Scott BL, Sandmaier BM, Lee SJ, Estey EH, Percival MM. Kopmar NE, et al. Among authors: scott bl. Transplant Cell Ther. 2024 Jul;30(7):727.e1-727.e8. doi: 10.1016/j.jtct.2024.05.002. Epub 2024 May 5. Transplant Cell Ther. 2024. PMID: 38710302
In this proof-of-principle feasibility study, we included adults age 18 to 75 years with R/R myeloid malignancies with 10% blood/marrow blasts at diagnosis who were eligible for a reduced-intensity HCT. Subjects received reinduction chemotherapy with cladribine, cytarabine …
In this proof-of-principle feasibility study, we included adults age 18 to 75 years with R/R myeloid malignancies with 10% blood/marr …
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.
Babushok DV, DeZern AE, de Castro CM, Rogers ZR, Beenhouwer D, Broder MS, Fanning SR, Gibbs SN, Hanna R, Maciejewski JP, Scott BL, Tantravahi SK, Wlodarski MW, Yermilov I, Patel BJ. Babushok DV, et al. Among authors: scott bl. Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642. Blood Adv. 2024. PMID: 38669341 Free PMC article.
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML.
Orvain C, Ali N, Othus M, Rodríguez-Arbolí E, Milano F, Le CM, Sandmaier BM, Scott BL, Appelbaum FR, Walter RB. Orvain C, et al. Among authors: scott bl. Am J Hematol. 2024 May;99(5):862-870. doi: 10.1002/ajh.27259. Epub 2024 Feb 21. Am J Hematol. 2024. PMID: 38380817
Multiparameter flow cytometry (MFC) measurable residual disease (MRD) before allogeneic hematopoietic cell transplantation (HCT) independently predicts poor outcomes in acute myeloid leukemia (AML). Conversely, its prognostic value in the newly defined disease entity, myel …
Multiparameter flow cytometry (MFC) measurable residual disease (MRD) before allogeneic hematopoietic cell transplantation (HCT) independent …
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
Gagelmann N, Hobbs GS, Campodonico E, Helbig G, Novak P, Schroeder T, Schneider A, Rautenberg C, Reinhardt HC, Bosques L, Heuser M, Panagiota V, Thol F, Gurnari C, Maciejewski JP, Ciceri F, Rathje K, Robin M, Pagliuca S, Rubio MT, Rocha V, Funke V, Hamerschlak N, Salit R, Scott BL, Duarte F, Mitrus I, Czerw T, Greco R, Kröger N. Gagelmann N, et al. Among authors: scott bl. Am J Hematol. 2024 May;99(5):844-853. doi: 10.1002/ajh.27252. Epub 2024 Feb 15. Am J Hematol. 2024. PMID: 38357714
123 results